Clinical implication of cardiovascular hormones
Clinical implication of cardiovascular hormones
批准号:
10307026
负责人:
NAKAO Kazuwa
金额:
$24.83万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A).
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2000
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We previously reported that, using in vivo myocytes-nonmyocytes co-culture model, endothelin-1 secreted from nonmyocytes are involved in the process of cardiac hypertrophy. In this study, we examined a role of CT-1, a novel interleukin-6 related cytokine having ability to evoke cardiac cell hypertrophy, in the myocytes-nonmyocytes interaction in an in vitro model of cardiac hypertrophy. We showed that CT-1 plays a role in the hypertrophic process in the co-culture, suggesting a role of CT-1 as a local regulator during cardiac hypertrophy.BNP is a cardiac hormonc produced primarily by ventricular myocytes. In this study, we generated mice with targeted disruption of BNP (BNP^<-/-> mice). We observed multifocal fibrotic lesions in the ventriceles from BNP^<-/-> mice. No signs of systemic hypertension and ventricular hypertrophy are noted in BNP^<-/-> mice. In response to ventricular pressure overload, focal fibrotic lesions are increased in size and number in BNP^<-/-> mice, whereas no f … More ocal fibrotic changes arc found in wild-type littermates. This study establishes BNP as a cardiomyocyte-derived antifibrotic factor in vivo and provides cvidence for its role as a local regulator of ventricular remodeling.CNP occurs in a variety of central and peripheral tissues, where it acts as an autocrine and paracrinre regulator. In this study, we generated mice with targeted disruption of CNP(CNP^<-/-> mice).The CNP^<-/-> mice show severe dwarfism as a result of imparired endochondral ossification. They are all viable perinatally, but less than half can survive during postnatal developmcnt. The skeletal phenotypes are histologically similar to those seen in patients with achondroplasia, the most common genetic form of human dwarfism. Targeted expression of CNP in the growth plate chondrocytes can rescue the skeletal defect of CNP^<-/-> micc and allow their prolonged survival. This study demonstrates that CNP acts locally as a positive regulator of endochondral ossification in vivo and suggests its pathophysiological and therapcutic implication in some forms of skeletal dysplasia. Less
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
H.Chusho et al.: "Dwarfism and early death in mice lacking C-type natriuretic peptide."Proc.Natl.Acad.Sci.USA. (in press). (2001)
H.Chusho 等人:“缺乏 C 型利钠肽的小鼠出现侏儒症和早期死亡。”Proc.Natl.Acad.Sci.USA。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Koichiro Kuwahara et al.: "Involvement of cardiotrophin-1 in cardiac myocyte-nonmyocyte interactions during hypertrophy of rat cardiac myocytes in vitro"Circulation. 100. 1116-1124 (1999)
Koichiro Kuwahara 等人:“心肌营养蛋白-1 参与体外大鼠心肌细胞肥大过程中心肌细胞-非肌细胞相互作用”循环。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.Chusho, N.Tamura, Y.Ogawa, A.Yasoda, M.Suda, T.Miyazawa, K.Nakamura, K.Nakao, T.Kurihara, Y.Komatsu, H.Itoh, K.Tanaka, Y.Saito, M.Katsuki, and K.Nakao: "Dwarfism and early death in mice lacking C-type natriuretic peptide."Proc.Natl.Acad.USA. (in press).
H.Chosho、N.Tamura、Y.Okawa、A.Yasoda、M.Suda、T.Miyazawa、K.Nakamura、K.Nakao、T.Kurihara、Y.Komatsu、H.Itoh、K.Tanaka、Y.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
N.Tamura, Y.Ogawa, H.Chusho, K.Nakamura, K.Nakao, M.Suda, M.Kasahara, R.Hashimoto, G.Katsuura, M.Mukoyama, H.Itoh, Y.Saito, I.Tanaka, H.Otani M.Katsuki, and K.Nakao: "Cardiac fibrosis in mice lacking brain natriuretic peptide."Proc.Natl.Acad.Sci.USA. 97.
N.Tamura、Y.Okawa、H.Chosho、K.Nakamura、K.Nakao、M.Suda、M.Kasahara、R.Hashimoto、G.Katsuura、M.Mukoyama、H.Itoh、Y.Saito、I。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
K.Kuwahara et al.: "Involvement of cardiotrophin-1 in cardiac myocyte-nonmyocite interactions during hypertrophy of rat cardiac myocytes in vitro." Cirulation. (in press) (1999)
K.Kuwahara 等人:“在体外大鼠心肌细胞肥大过程中,心肌营养素-1 参与心肌细胞与非心肌细胞的相互作用。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 21 条
Development and analysis of model rats for diseases of endocrinology and metabolism
-
批准号:23659476
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:NAKAO Kazuwa
-
依托单位:
Physiological Function of Hormones Derived from Mesenchymal Cells and Its Failure
-
批准号:21229013
-
项目类别:Grant-in-Aid for Scientific Research (S)
-
资助金额:$135.62万
-
财政年份:2009
-
负责人:NAKAO Kazuwa
-
依托单位:
Translational research and development of novel diagnostic/therapeutic modalities for metabolic syndrome based on adipocyte endocrinology and adiposcience
-
批准号:16109007
-
项目类别:Grant-in-Aid for Scientific Research (S)
-
资助金额:$73.22万
-
财政年份:2004
-
负责人:NAKAO Kazuwa
-
依托单位:
Molecular Basis of Centrally-controled Energy Homeostasis -Focusing on Leptin Resistance-
-
批准号:13307033
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$35.36万
-
财政年份:2001
-
负责人:NAKAO Kazuwa
-
依托单位:
Molecular Study on Physiological and Clinical Significance of Adrenomedullin
-
批准号:10218204
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$39.81万
-
财政年份:1998
-
负责人:NAKAO Kazuwa
-
依托单位:
New Animal Models Of Leaness And Obesity by Genetic Engineering and its Application to Therapy
-
批准号:09557080
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.3万
-
财政年份:1997
-
负责人:NAKAO Kazuwa
-
依托单位:
Molecular and Clinical Study of Cardiovascular Hormones
-
批准号:08044272
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$4.8万
-
财政年份:1996
-
负责人:NAKAO Kazuwa
-
依托单位:
Development of novel mouse models deficient in vasoactive substances-Clinical implication of the natriuretic peptide family and its application to gene therapy-
-
批准号:07557072
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$7.17万
-
财政年份:1995
-
负责人:NAKAO Kazuwa
-
依托单位:
Molecular Biology of Vasoactive Substances
-
批准号:06404037
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$22.21万
-
财政年份:1994
-
负责人:NAKAO Kazuwa
-
依托单位:
Molecular biology of vasoactive substances
-
批准号:06044129
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$2.82万
-
财政年份:1994
-
负责人:NAKAO Kazuwa
-
依托单位:
Development of a CNP related drug as a new treatment for hypertension and arteriosclerosis.
-
批准号:05557051
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$6.34万
-
财政年份:1993
-
负责人:NAKAO Kazuwa
-
依托单位:
Development and practical use of supersensitive assays for peptides with monoclonal antibodies
-
批准号:02557112
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$7.62万
-
财政年份:1990
-
负责人:NAKAO Kazuwa
-
依托单位:
Clinical application and elucidation of significance of natriuretic peptide family
-
批准号:01480288
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.29万
-
财政年份:1989
-
负责人:NAKAO Kazuwa
-
依托单位:
Significance and clinical application of atrial natriuretic polypeptide as hormone and neuropeptide
-
批准号:62570512
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.22万
-
财政年份:1987
-
负责人:NAKAO Kazuwa
-
依托单位:
国内基金
海外基金
登录
查看更多内容
利用单细胞测序技术研究TTTS受血儿羊水NT-BNP起源及羊水亚细胞群图谱
-
批准号:2023JJ40951
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:蹇文艳
-
依托单位:
转录因子TBX20调控BNP/NPR1通路介导慢性痒的机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:Meng Jianghui
-
依托单位:
S1P/S1PR1/IL-1β/BNP信号通路在慢性前列腺炎/慢性骨盆疼痛综合征 (CP/CPPS)中的作用及机制研究
-
批准号:82060144
-
项目类别:地区科学基金项目
-
资助金额:34.0万元
-
批准年份:2020
-
负责人:孙庭
-
依托单位:
S1P/S1PR1/IL-1β/BNP信号通路在慢性前列腺炎/慢性骨盆疼痛综合征 (CP/CPPS)中的作用及机制研究
-
批准号:--
-
项目类别:--
-
资助金额:34万元
-
批准年份:2020
-
负责人:孙庭
-
依托单位:
全光控蛋白标志物BNP/NT-proBNP即时检测设备研制
-
批准号:51927805
-
项目类别:国家重大科研仪器研制项目
-
资助金额:600.7万元
-
批准年份:2019
-
负责人:俞燕蕾
-
依托单位:
“心应夏”生理机制的研究——松果腺在夏冬对心肌细胞内分泌系统(AMP-BNP-AAP-RAS)和血管内皮内分泌免疫因子的影响
-
批准号:81973716
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:刘晓燕
-
依托单位:
BNP在猪卵母细胞成熟中的作用机制及其应用的研究
-
批准号:31601203
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2016
-
负责人:张文强
-
依托单位:
脑钠肽(BNP)及其受体(NPR-A)在慢性前列腺炎/慢性骨盆疼痛综合症(CP/CPPS)中的作用及机理研究
-
批准号:81460137
-
项目类别:地区科学基金项目
-
资助金额:47.0万元
-
批准年份:2014
-
负责人:孙庭
-
依托单位:
长效BNP治疗心力衰竭的作用及机制研究
-
批准号:31271220
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:朱妙章
-
依托单位:
心源性猝死心肌组织中BNP的变化规律及法医学应用
-
批准号:81273343
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2012
-
负责人:朱宝利
-
依托单位: